Name: NLB 2016 Case 4,5,6 Relapsed Myeloma, Treatment for Relapsed MM, Drugs in Development
Uploaded: 2016-06-10T08:00:00+08:00
Duration: PT27,39S
Description: In this video, IMF Nurse Leadership Board members Tiffany Richards RN, MS, ANP-C and Beth Faiman, PhD , MSN, APRN-BC, AOCN® discuss treatments for relapsed myeloma.

Case Studies #4, #5, #6: Relapsed Myeloma, Treatment for Relapsed Myeloma, Drugs in Development

Tiffany Richards, RN, MS, ANP-C
Beth Faiman, PhD , MSN, APRN-BC, AOCN®

Start at page 64

iStopMM 2 text overlaid on image of a valley

Two-Year Follow-Up of the IMF's iStopMM (Iceland Screens Treats or Prevents Myeloma)

How common are low platelet counts after autologous stem cell transplant?

IMWG Conference Series - Copenhagen 2016: What is the impact of the new diagnostic criteria?

NLB 2016: Case #2, 3 Bone Health, Renal Health, 1+Prior Therapies, Immunotherapy, Clonal Evolution

Share On

Donation

NLB 2016 Case 4,5,6 Relapsed Myeloma, Treatment for Relapsed MM, Drugs in Development

Two-Year Follow-Up of the IMF's iStopMM (Iceland Screens Treats or Prevents Myeloma)

How common are low platelet counts after autologous stem cell transplant?

Give Where Most Needed